BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29402961)

  • 21. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.
    Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M
    Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration.
    Meng F; Joshi B; Nabi IR
    PLoS One; 2015; 10(5):e0126056. PubMed ID: 25942420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
    Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
    J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility.
    Grubisha MJ; Cifuentes ME; Hammes SR; Defranco DB
    Mol Endocrinol; 2012 Jun; 26(6):940-54. PubMed ID: 22593181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance.
    Panic A; Ketteler J; Reis H; Sak A; Herskind C; Maier P; Rübben H; Jendrossek V; Klein D
    Sci Rep; 2017 Jan; 7():41138. PubMed ID: 28112237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of caveolin‑1 upregulates the expression of growth factors and regulators in co‑culture of fibroblasts with cancer cells.
    Shi XY; Xiong LX; Xiao L; Meng C; Qi GY; Li WL
    Mol Med Rep; 2016 Jan; 13(1):744-52. PubMed ID: 26647977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CpG island shore methylation regulates caveolin-1 expression in breast cancer.
    Rao X; Evans J; Chae H; Pilrose J; Kim S; Yan P; Huang RL; Lai HC; Lin H; Liu Y; Miller D; Rhee JK; Huang YW; Gu F; Gray JW; Huang TM; Nephew KP
    Oncogene; 2013 Sep; 32(38):4519-28. PubMed ID: 23128390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene.
    Ifere GO; Equan A; Gordon K; Nagappan P; Igietseme JU; Ananaba GA
    Cancer Epidemiol; 2010 Aug; 34(4):461-71. PubMed ID: 20466611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
    Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
    J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular adaptor molecules and AR signalling in the tumour microenvironment.
    Reebye V; Frilling A; Habib NA; Mintz PJ
    Cell Signal; 2011 Jun; 23(6):1017-21. PubMed ID: 21130868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.
    Tse EY; Ko FC; Tung EK; Chan LK; Lee TK; Ngan ES; Man K; Wong AS; Ng IO; Yam JW
    J Pathol; 2012 Mar; 226(4):645-53. PubMed ID: 22072235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin delays castration‑resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin‑1.
    Gao Y; Li L; Li T; Ma L; Yuan M; Sun W; Cheng HL; Niu L; Du Z; Quan Z; Fan Y; Fan J; Luo C; Wu X
    Int J Oncol; 2019 Jun; 54(6):2054-2068. PubMed ID: 31081050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prometastatic NEDD9 Regulates Individual Cell Migration via Caveolin-1-Dependent Trafficking of Integrins.
    Kozyulina PY; Loskutov YV; Kozyreva VK; Rajulapati A; Ice RJ; Jones BC; Pugacheva EN
    Mol Cancer Res; 2015 Mar; 13(3):423-38. PubMed ID: 25319010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-talk between Dopachrome Tautomerase and Caveolin-1 Is Melanoma Cell Phenotype-specific and Potentially Involved in Tumor Progression.
    Popa IL; Milac AL; Sima LE; Alexandru PR; Pastrama F; Munteanu CVA; Negroiu G
    J Biol Chem; 2016 Jun; 291(24):12481-12500. PubMed ID: 27053106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coordinated expression of galectin-3 and caveolin-1 in thyroid cancer.
    Shankar J; Wiseman SM; Meng F; Kasaian K; Strugnell S; Mofid A; Gown A; Jones SJ; Nabi IR
    J Pathol; 2012 Sep; 228(1):56-66. PubMed ID: 22513979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cosuppression of Sprouty and Sprouty-related negative regulators of FGF signalling in prostate cancer: a working hypothesis.
    Assinder SJ; Beniamen D; Lovicu FJ
    Biomed Res Int; 2015; 2015():827462. PubMed ID: 26075267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caveolin-1 Confers Resistance of Hepatoma Cells to Anoikis by Activating IGF-1 Pathway.
    Tang W; Feng X; Zhang S; Ren Z; Liu Y; Yang B; lv B; Cai Y; Xia J; Ge N
    Cell Physiol Biochem; 2015; 36(3):1223-36. PubMed ID: 26138883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway.
    Trimmer C; Whitaker-Menezes D; Bonuccelli G; Milliman JN; Daumer KM; Aplin AE; Pestell RG; Sotgia F; Lisanti MP; Capozza F
    Cancer Res; 2010 Oct; 70(19):7489-99. PubMed ID: 20709760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma.
    Korhan P; Erdal E; Kandemiş E; Cokaklı M; Nart D; Yılmaz F; Can A; Atabey N
    PLoS One; 2014; 9(8):e105278. PubMed ID: 25148256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.
    Camões MJ; Paulo P; Ribeiro FR; Barros-Silva JD; Almeida M; Costa VL; Cerveira N; Skotheim RI; Lothe RA; Henrique R; Jerónimo C; Teixeira MR
    PLoS One; 2012; 7(11):e49819. PubMed ID: 23185447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.